Bayesian approach enabled objective comparison of multiple human iPSC-derived Cardiomyocytes' Proarrhythmia sensitivities.

被引:1
|
作者
Wakatsuki, Tetsuro [1 ,2 ]
Daily, Neil [2 ]
Hisada, Sunao [1 ,3 ]
Nunomura, Kazuto [1 ,4 ]
Lin, Bangzhong [1 ,4 ]
Zushida, Ko [1 ,5 ]
Honda, Yayoi [1 ,6 ]
Asyama, Mahoko [1 ,7 ]
Takasuna, Kiyoshi [1 ,8 ,9 ]
机构
[1] Heart Team, Consortium Safety Assessment Using Human iPS Cell, Tokyo, Japan
[2] Invivosci Inc, Madison, WI 53719 USA
[3] KK Syst Div, Hamamatsu Photon, Shizuoka 4313196, Japan
[4] Osaka Univ, Grad Sch Pharmaceut Sci, Ctr Supporting Drug Discovery & Life Sci Res, Osaka 5650871, Japan
[5] Fujifilm Wako Pure Chem Corp, Osaka 5408605, Japan
[6] Sumika Chem Anal Serv Ltd SCAS, Osaka 5540022, Japan
[7] Mitsubishi Tanabe Pharm Corp, Kanagawa 2518555, Japan
[8] Daiichi Sankyo RD Novare Co Ltd, Tokyo 1348630, Japan
[9] Axcelead Drug Discovery Partners Inc, Kanagawa, 2510012, Japan
关键词
Bayesian; Cardiac safety; Cardiomyocyte; Computational modeling; Data science; High; -throughput; Imaging; Methods; Personalized medicine; Proarrhythmia; QT PROLONGATION; SAFETY; MOXIFLOXACIN; BOOTSTRAP;
D O I
10.1016/j.vascn.2024.107531
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The one-size-fits-all approach has been the mainstream in medicine, and the well-defined standards support the development of safe and effective therapies for many years. Advancing technologies, however, enabled precision medicine to treat a targeted patient population (e.g., HER2+ cancer). In safety pharmacology, computational population modeling has been successfully applied in virtual clinical trials to predict drug-induced proarrhythmia risks against a wide range of pseudo cohorts. In the meantime, population modeling in safety pharmacology experiments has been challenging. Here, we used five commercially available human iPSC-derived cardiomyocytes growing in 384-well plates and analyzed the effects of ten potential proarrhythmic compounds with four concentrations on their calcium transients (CaTs). All the cell lines exhibited an expected elongation or shortening of calcium transient duration with various degrees. Depending on compounds inhibiting several ion channels, such as hERG, peak and late sodium and L-type calcium or IKs channels, some of the cell lines exhibited irregular, discontinuous beating that was not predicted by computational simulations. To analyze the shapes of CaTs and irregularities of beat patterns comprehensively, we defined six parameters to characterize compoundinduced CaT waveform changes, successfully visualizing the similarities and differences in compound-induced proarrhythmic sensitivities of different cell lines. We applied Bayesian statistics to predict sample populations based on experimental data to overcome the limited number of experimental replicates in high-throughput assays. This process facilitated the principal component analysis to classify compound-induced sensitivities of cell lines objectively. Finally, the association of sensitivities in compound-induced changes between phenotypic parameters and ion channel inhibitions measured using patch clamp recording was analyzed. Successful ranking of compound-induced sensitivity of cell lines was in lined with visual inspection of raw data.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] Effect of hydroxychloroquine on proarrhythmia risk assessment using human iPSC-derived cardiomyocytes
    Yanagida, Shota
    Satsuka, Ayano
    Hayashi, Sayo
    Ono, Atsushi
    Kanda, Yasunari
    [J]. JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2021, 111
  • [2] iPSC-Derived Human Cardiomyocytes
    Anson, Blake
    [J]. GENETIC ENGINEERING & BIOTECHNOLOGY NEWS, 2010, 30 (10): : 18 - 19
  • [3] Human iPSC-Derived Cardiomyocytes
    Salvagiotto, Giorgio
    Sirenko, Oksana
    Hesley, Jayne
    Kattman, Steven
    [J]. GENETIC ENGINEERING & BIOTECHNOLOGY NEWS, 2012, 32 (08): : 28 - 29
  • [4] TRANSCRIPTOMIC CHARACTERIZATION OF HUMAN IPSC-DERIVED CARDIOMYOCYTES
    Gomes-Silva, Beatriz
    Ribeiro, Marta
    Furtado, Marta
    Martins, Sandra
    Carvalho, Teresa
    Barbosa, Pedro
    Savisaar, Rosina
    Carmo-Fonseca, Maria
    [J]. MEDICINE, 2022, 101 (30)
  • [5] Assessment of mitophagy in human iPSC-derived cardiomyocytes
    Yang, Mingchong
    Fu, Ji-Dong
    Zou, Jizhong
    Sridharan, Divya
    Zhao, Ming-Tao
    Singh, Harpreet
    Krigman, Judith
    Khan, Mahmood
    Xin, Gang
    Sun, Nuo
    [J]. AUTOPHAGY, 2022, 18 (10) : 2481 - 2494
  • [6] Comparable calcium handling of human iPSC-derived cardiomyocytes generated by multiple laboratories
    Hwang, Hyun Seok
    Kryshtal, Dmytro O.
    Feaster, T. K.
    Sanchez-Freire, Veronica
    Zhang, Jianhua
    Kamp, Timothy J.
    Hong, Charles C.
    Wu, Joseph C.
    Knollmann, Bjoern C.
    [J]. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2015, 85 : 79 - 88
  • [7] Differentiation and validation of human iPSC-derived atrial cardiomyocytes
    Sutton, Kathy
    El Haou, Said
    Williams, Sarah
    Devalla, Harsha
    Stoelzle-Feix, Sonja
    Juhasz, Krisztina
    Doerr, Leo
    Beckler, Matthias
    Haarmann, Claudia
    George, Michael
    Passier, Robert
    Fertig, Niels
    Rogers, Marc
    [J]. JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2018, 93 : 168 - 168
  • [8] Imaging cAMP nanodomains in human iPSC-derived cardiomyocytes
    Charriere, Camille
    [J]. NATURE REVIEWS CARDIOLOGY, 2024, 21 (07) : 441 - 441
  • [9] Measuring hypertrophy in neonatal rat primary cardiomyocytes and human iPSC-derived cardiomyocytes
    Bourque, Kyla
    Hawey, Cara
    Jones-Tabah, Jace
    Petrin, Darlaine
    Martin, Ryan D.
    Sun, Yi Ling
    Hebert, Terence E.
    [J]. METHODS, 2022, 203 : 447 - 464
  • [10] Impact of serum in the pharmacological response of human iPSC-derived cardiomyocytes
    Goineau, Sonia
    Legrand, Christophe
    Hunault, Marion
    Froget, Guillaume
    Castagne, Vincent
    [J]. JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2018, 93 : 163 - 163